BSY Q1 2026 Earnings EPS Beats Estimates by Nearly 6 MQ Q1 2026 Earnings Significant EPS Beat Fails to Lift Stock Amid Revenue Uncertainty SPG Q1 2026 Earnings EPS Slightly Misses Estimates Shares Edge Higher Ernexa Therapeutics ERNA Q3 2023 Earnings Net loss of 103 per share highlights ongoing clinical investment stock declines 377 ILPT Q1 2026 Earnings NarrowerthanExpected Loss as Surplus of 3137 Beats Street Estimates CREG Q1 2026 Earnings Loss Per Share as Stock Rises on No Estimate Surprise